Global Nephrology Stents and Catheters Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Nephrology Catheters, Balloon Catheters, Malécot Catheters, J Tip Catheters, Pigtail Catheters, Nephrology Stents, Metal Stents, and Plastic Stents.

By End User;

Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn580421668 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Nephrology Stents and Catheters Market (USD Million), 2021 - 2031

In the year 2024, the Global Nephrology Stents and Catheters Market was valued at USD 1147.40 million. The size of this market is expected to increase to USD 1725.26 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.

The growth of the nephrology stents and catheter market was significantly impacted by the COVID-19 pandemic. Government-imposed lockdown measures to prevent the spread of the virus led to the suspension of patient visits to hospitals, clinics, and dialysis centers, severely affecting patients with nephrology conditions. According to a July 2021 article in *Frontiers in Physiology*, the diagnosis of various kidney diseases was delayed during the pandemic due to the postponement of non-urgent tests and visits, stemming from the closure of medical services. This delay in kidney disease diagnosis affected the histological examination processes early in the pandemic, reducing the demand for nephrology stents and catheters. However, as non-essential surgical procedures resumed later in the pandemic, the market began to recover and is expected to continue this upward trend over the forecast period.

Several factors are driving the market, including the increasing incidence of nephrology disorders, a rising geriatric population, and technological advancements in catheter and stent materials. For instance, data from the Australian Institute of Health and Welfare published in August 2022 indicated that in 2021, chronic kidney diseases affected 292 males and 677 females per 100,000 population among Aboriginal and Torres Strait Islanders. Additionally, Indigenous Australians were 4.6 times more likely to be diagnosed with chronic kidney disease than their non-Indigenous counterparts. Such statistics suggest a growing demand for surgeries, which, in turn, is expected to increase the demand for nephrology stents and catheters, propelling market growth.

The market growth is also bolstered by a strong pipeline of nephrology stents and catheters. A January 2022 research journal from the *Medical Device Network* reported a 75.0% rise in pipeline nephrology and urology products globally in 2021 compared to 2020. Advanced-stage devices (in clinical trials, in the approval process, or already approved) accounted for 45.65% of medical devices in 2021, up from 37.93% in 2020. Additionally, the number of devices at the approval stage doubled in 2021 compared to 2020. Approximately 43.0% of pipeline nephrology and urology devices in 2021 were expected to receive regulatory approval by the end of 2025, with urinary catheters leading the category at 6.0%. This increase in regulatory approvals is expected to drive the demand for nephrology stents and catheters, leading to substantial market growth over the forecast period.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Nephrology Stents and Catheters Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of Kidney Diseases
        2. Aging Population
        3. Technological Advancements
      2. Restraints
        1. High Cost of Procedures
        2. Stringent Reimbursement Policies
      3. Opportunities
        1. Focus on Minimally Invasive Procedures
        2. Development of Home Dialysis Therapies
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Nephrology Stents and Catheters Market, By Product Type, 2021 - 2031 (USD Million)
      1. Nephrology Catheters
      2. Balloon Catheters
      3. Malécot Catheters
      4. J Tip Catheters
      5. Pigtail Catheters
      6. Nephrology Stents
      7. Metal Stents
      8. Plastic Stents
    2. Global Nephrology Stents and Catheters Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Specialty Clinics
    3. Global Nephrology Stents and Catheters Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Angiodynamics, Inc
      2. Rocamed
      3. Ameco Medical Industries
      4. Boston Scientific Corporation
      5. UROMED
      6. Teleflex Incorporated
      7. Cardinal Health Inc., C. R. Bard, Inc
      8. Envaste Limited
      9. Merit Medical Systems
  7. Analyst Views
  8. Future Outlook of the Market